CLARITY PHARMACEUTICALS LTD

2.06%

$4.46

Market Cap $1.658B

Healthcare Biotechnology

Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical... Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical company. The Company is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. It is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. It has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. LATEST: Race Oncology Accelerates Game-Changing Cancer Drug.

Latest Threads

Tag

Subject

CU6

CU6 - ASX Charts

53 54 55

01/08/25

3.2K

1.2M

01/08/25

Last post BeansInc

3.2K

1.2M

CU6

Ann: Cleansing Notice

01/08/25

1.8K

01/08/25

Last post GreatMinds

1.8K

CU6 Biotech

(Potential) short squeeze

2 3

01/08/25

150

44K

01/08/25

Last post wednesdayschild

150

44K

CU6

Ann: Ceasing to be a substantial holder

01/08/25

269

01/08/25

Last post

ASX News

269

CU6

Ann: Ceasing to be a substantial holder

01/08/25

234

01/08/25

Last post

ASX News

234

CU6

Ann: Ceasing to be a substantial holder

01/08/25

251

01/08/25

Last post

ASX News

251

CU6

CU6 - Media and Industry News

20 21 22

01/08/25

1.3K

600K

01/08/25

Last post jinvstr

1.3K

600K

CU6

Ann: Clarity successfully completes $203 million institutional pl

2 3

01/08/25

149

43K

01/08/25

Last post bosco99

149

43K

See All Discussions

Timeline

Ceasing to be a substantial holder
01 Aug 15:02	Share

Ceasing to be a substantial holder
01 Aug 15:00	Share

Ceasing to be a substantial holder
01 Aug 14:59	Share

Cleansing Notice
01 Aug 09:39	Share

Ceasing to be a substantial holder
31 Jul 16:16	Share

Quarterly Activities/Appendix 4C Cash Flow Report
31 Jul 11:57	Share

Application for quotation of securities - CU6
31 Jul 11:25	Share

Becoming a substantial holder
29 Jul 19:22	Share

Proposed issue of securities - CU6
28 Jul 09:44	Share

Clarity successfully completes $203 million institutional pl
28 Jul 09:42	Share

Change in substantial holding
24 Jul 08:18	Share

Co-PSMA trial recruitment successfully completed
17 Jul 09:45	Share

Notification of cessation of securities - CU6
14 Jul 15:47	Share

Cleansing Notice
04 Jul 10:41	Share

Application for quotation of securities - CU6
04 Jul 10:37	Share

Notice of initial substantial holder
04 Jul 09:12	Share

Change of Director's Interest Notice - M Parker
04 Jul 09:12	Share

Change of Director's Interest Notice - C Biggin
04 Jul 09:08	Share

Change of Director's Interest Notice - A Taylor
04 Jul 09:07	Share

Cleansing Notice
02 Jul 11:51	Share

Application for quotation of securities - CU6
02 Jul 11:48	Share

Change in substantial holding
01 Jul 08:27	Share

Cleansing Notice
24 Jun 09:35	Share

Application for quotation of securities - CU6
24 Jun 09:31	Share

Clarity enters a Commercial Manufacturing Agreement
17 Jun 09:36	Share

SABRE topline results
13 Jun 09:58	Share

DISCO topline results
05 Jun 09:49	Share

Ceasing to be a substantial holder
05 Jun 08:22	Share

Notification regarding unquoted securities - CU6
30 May 11:08	Share

First patient imaged in Phase III AMPLIFY trial
29 May 09:34	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $4.46		Change 0.090(2.06%)		Mkt cap ! $1.658B

Open	High	Low	Value	Volume
$4.37	$4.64	$4.36	$19.15M	4.236M

Buyers (Bids)

No.	Vol.	Price($)
4	58340	$4.45

Sellers (Offers)

Price($)	Vol.	No.
$4.46	365	5

View Market Depth

No.	Vol.	Price($)
4	58340	4.450
2	25225	4.440
2	10200	4.430
1	71	4.420
3	4246	4.410

Price($)	Vol.	No.
4.460	365	5
4.480	6628	3
4.490	2500	1
4.520	14195	4
4.550	32025	2

Last trade - 16.15pm 01/08/2025 (20 minute delay)

CU6 (ASX) Chart

CLARITY PHARMACEUTICALS LTD

Latest Threads

Redcastle Resources Delivers Positive Scoping Study for Queen Alexandra

Timeline

Featured News

Latest Videos

Clarity Pharmaceuticals' (ASX:CU6) theranostic prostate cancer trial progresses to highest dose level

10 Aug 2023 12:13 (AEST)

Latest Articles

Clarity scribes deal on delivery of copper 64 isotopes

Clarity Pharmaceuticals Ltd has seen its share price leap after it announced a deal with Nusano to deliver Cu-64 isotopes

Another win for Clarity at FDA as imaging agent fast-tracked for complex prostate cancer

For those unlucky enough to have received a testicular castration to treat prostate cancer, only for it to come back, Clarity Pharmaceuticals’ (ASX:CU6) news on Wednesday morning could offer crucial moral support.For those patients (who have also already received first-stage less ...

Clarity jumps as FDA awards fast track status for PET scan imaging agent

Clarity Pharmaceuticals (ASX:CU6) has seen the U.S. FDA fast-track its prostate cancer imaging compound for use in PET scans on patients with recurring prostate cancer. The stock jumped 4% in the first hour of trade to $4.23 in what is likely a welcome move for shareholders who have already seen ...

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News